U.S. market Closed. Opens in 17 hours 8 minutes

RVNC | Revance Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue234.04M132.56M77.80M15.32M413.00K3.73M262.00K300.00K300.00K383.00K617.00K717.00K557.00K
Cost of Revenue88.06M51.67M23.41M4.77M102.86MN/AN/AN/AN/AN/AN/AN/A5.00K
Gross Profit145.98M80.90M54.39M10.56M-102.45M3.73MN/AN/AN/AN/A617.00K717.00K552.00K
Operating Expenses366.71M353.07M329.06M283.72M164.87M146.36M117.76M79.46M72.62M52.43M38.84M43.90M28.29M
Selling, General & Admin292.24M223.93M198.82M151.85M62.01M53.86M37.40M29.07M25.09M19.04MN/AN/AN/A
Research & Development74.47M101.29M116.25M125.80M102.86M92.50M80.36M50.38M47.53M33.39M27.83M32.71M22.73M
Other Operating Expenses-838.00K27.85M13.99M6.08M-303.00K-773.00KN/AN/AN/AN/A11.01M11.20M5.55M
Operating Income-220.72M-272.17M-274.68M-273.16M-164.46M-142.63M-120.42M-79.16M-72.32M-52.05M-38.23M-43.19M-27.74M
Other Expenses / Income-102.96M-83.55M-6.63M-11.55M5.03M-913.00K-163.00K-10.11M-1.16M-10.87M-14.22M-15.07M-17.12M
Before Tax Income-323.69M-355.72M-281.31M-284.71M-159.43M-139.57M-120.59M-89.27M-73.48M-62.92M-52.45M-58.26M-44.86M
Income Tax Expenses300.00K700.00K5.51M-2.62M-3.21M3.00MN/AN/AN/AN/AN/AN/AN/A
Net Income-323.99M-356.42M-286.82M-282.09M-156.22M-142.57M-120.59M-89.27M-73.48M-62.92M-52.45M-58.26M-44.86M
Interest Expenses19.36M16.47M6.27M15.15MN/A44.00K457.00K1.08M1.19M10.67M15.16M28.96M17.79M
Basic Shares Outstanding84.60M72.71M67.51M58.01M43.46M36.17M30.10M28.11M24.34M19.39M17.74M2.15M7.18M
Diluted Shares Outstanding84.60M72.71M67.51M58.01M43.46M36.17M30.10M28.11M24.34M19.39M17.74M2.15M7.18M
EBITDA-207.03M-241.61M-261.11M-263.36M-159.23M-139.38M-118.66M-86.74M-70.29M-50.19M-35.40M-27.52M-25.09M
EBITDA Margin-88.46%-182.26%-335.63%-1,718.47%-38,554.48%-3,737.84%-45,290.84%-28,914.33%-23,430.33%-13,105.48%-5,737.93%-3,838.63%-4,504.49%
EBIT-304.33M-339.25M-275.04M-269.56M-159.43M-139.52M-120.13M-88.19M-72.29M-52.24M-37.28M-29.30M-27.07M
EBIT Margin-130.03%-255.91%-353.53%-1,758.96%-38,602.66%-3,741.59%-45,851.15%-29,396.00%-24,095.33%-13,640.99%-6,042.79%-4,086.47%-4,860.50%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙